Megakaryocyte polyploidization: role in platelet production

References

• Bluteau D, Glembotsky AC, Raimbault A, Balayn N, Gilles L, Rameau P, Nurden P, Alessi MC, Debili N, Vainchenker W, et al. Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression. Blood 2014;120:2708–2718. doi:10.1182/blood-2012-04-422337
   Web of Science ®Google Scholar
• Breton-Gorius J, Favier R, Guichard J, Cherif D, Berger R, Debili N, Vainchenker W, Douay L. A new congenital dysmegakaryopoietic thrombocytopenia (Paris-Trousseau) associated with giant platelet alpha-granules and chromosome 11 deletion at 11q23. Blood 1995;85:1805–1814.
   PubMed Web of Science ®Google Scholar
• Raslova H, Komura E, Le Couedic JP, Larbret F, Debili N, Feunteun J, Danos O, Albagli O, Vainchenker W, Favier R. FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. J Clin Invest 2004;114:77–84. doi:10.1172/JCI21197
   PubMed Web of Science ®Google Scholar
• Balduini CL, Pecci A, Loffredo G, Izzo P, Noris P, Grosso M, Bergamaschi G, Rosti V, Magrini U, Ceresa IF, et al. Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis. Thromb Haemost 2004;91:129–140. doi:10.1160/TH03-05-0290
   PubMed Web of Science ®Google Scholar
• Ravid K, Lu J, Zimmet JM, Jones MR. Roads to polyploidy: the megakaryocyte example. J Cell Physiol 2002;190:7–20. Epub 2002/ 01/25. doi:10.1002/jcp.10035
   PubMed Web of Science ®Google Scholar
• Vainchenker W, Guichard J, Breton-Gorius J. [Differentiation of human megakaryocytes in culture starting from the primordial circulating cells in the newborn]. Comptes rendus hebdomadaires des seances de l’Academie des sciences Serie D: Sciences naturelles 1978;287:177–179. Epub 1978/ 07/17.
   PubMedGoogle Scholar
• Nagata Y, Muro Y, Todokoro K. Thrombopoietin-induced polyploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis. J Cell Biol 1997;139:449–457. Epub 1997/ 10/23. doi:10.1083/jcb.139.2.449
   PubMed Web of Science ®Google Scholar
• Vitrat N, Cohen-Solal K, Pique C, Le Couedic JP, Norol F, Larsen AK, Katz A, Vainchenker W, Debili N. Endomitosis of human megakaryocytes are due to abortive mitosis. Blood 1998;91:3711–3723. Epub 1998/ 06/20.
   PubMed Web of Science ®Google Scholar
• Geddis AE, Fox NE, Tkachenko E, Kaushansky K. Endomitotic megakaryocytes that form a bipolar spindle exhibit cleavage furrow ingression followed by furrow regression. Cell Cycle (georgetown, Tex) 2007;6:455–460. Epub 2007/ 02/22. doi:10.4161/cc.6.4.3836
   PubMed Web of Science ®Google Scholar
• Lordier L, Jalil A, Aurade F, Larbret F, Larghero J, Debili N, Vainchenker W, Chang Y. Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling. Blood 2008;112:3164–3174. Epub 2008/ 08/08. doi:10.1182/blood-2008-03-144956
   PubMed Web of Science ®Google Scholar
• Papadantonakis N, Makitalo M, McCrann DJ, Liu K, Nguyen HG, Martin G, Patel-Hett S, Italiano JE, Ravid K. Direct visualization of the endomitotic cell cycle in living megakaryocytes: differential patterns in low and high ploidy cells. Cell Cycle (georgetown, Tex) 2008;7:2352–2356. Epub 2008/ 08/05. doi:10.4161/cc.6325
   PubMed Web of Science ®Google Scholar
• Lordier L, Pan J, Naim V, Jalil A, Badirou I, Rameau P, Larghero J, Debili N, Rosselli F, Vainchenker W, et al. Presence of a defect in karyokinesis during megakaryocyte endomitosis. Cell Cycle (georgetown, Tex) 2012;11:4385–4389. Epub 2012/ 11/20. doi:10.4161/cc.22712
   PubMed Web of Science ®Google Scholar
• Leysi-Derilou Y, Robert A, Duchesne C, Garnier A, Boyer L, Pineault N. Polyploid megakaryocytes can complete cytokinesis. Cell Cycle (georgetown, Tex) 2010;9:2589–2599. Epub 2010/ 07/22. doi:10.4161/cc.9.13.12078
   PubMed Web of Science ®Google Scholar
• Sun S, Zimmet JM, Toselli P, Thompson A, Jackson CW, Ravid K. Overexpression of cyclin D1 moderately increases ploidy in megakaryocytes. Haematologica 2001;86:17–23. Epub 2001/ 01/09.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang Y, Kamen D, Lees E, Ravid K. Cyclin D3 is essential for megakaryocytopoiesis. Blood 1995;86:3783–3788. Epub 1995/ 11/15.
   PubMed Web of Science ®Google Scholar
• Zimmet JM, Toselli P, Ravid K. Cyclin D3 and megakaryocyte development: exploration of a transgenic phenotype. Stem Cells 1998;16:97–106. doi:10.1002/stem.5530160713
   PubMedGoogle Scholar
• Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, Rideout WM, Bronson RT, Gardner H, Sicinski P. Cyclin E ablation in the mouse. Cell 2003;114:431–443. doi:10.1016/s0092-8674(03)00645-7
   PubMed Web of Science ®Google Scholar
• Eliades A, Papadantonakis N, Ravid K. New roles for cyclin E in megakaryocytic polyploidization. J Biol Chem 2010;285:18909–18917. Epub 2010/ 04/16. doi:10.1074/jbc.M110.102145
   PubMed Web of Science ®Google Scholar
• Bermejo R, Vilaboa N, Cales C. Regulation of CDC6, geminin, and CDT1 in human cells that undergo polyploidization. Mol Biol Cell 2002;13:3989–4000. Epub 2002/ 11/14. doi:10.1091/mbc.e02-04-0217
   PubMed Web of Science ®Google Scholar
• Raslova H, Kauffmann A, Sekkai D, Ripoche H, Larbret F, Robert T, Le Roux DT, Kroemer G, Debili N, Dessen P, et al. Interrelation between polyploidization and megakaryocyte differentiation: a gene profiling approach. Blood 2007;109:3225–3234. Epub 2006/ 12/16. doi:10.1182/blood-2006-07-037838
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Endo H, Chikatsu N, Uchimaru K, Asano S, Fujita T, Nakahata T, Motokura T. Expression of p21(Cip1/Waf1/Sdi1) and p27(Kip1) cyclin-dependent kinase inhibitors during human hematopoiesis. Blood 1999;93:4167–4178.
   PubMed Web of Science ®Google Scholar
• Baccini V, Roy L, Vitrat N, Chagraoui H, Sabri S, Le Couedic JP, Debili N, Wendling F, Vainchenker W. Role of p21(Cip1/Waf1) in cell-cycle exit of endomitotic megakaryocytes. Blood 2001;98:3274–3282. Epub 2001/ 11/24. doi:10.1182/blood.v98.12.3274
   PubMed Web of Science ®Google Scholar
• Apostolidis PA, Woulfe DS, Chavez M, Miller WM, Papoutsakis ET. Role of tumor suppressor p53 in megakaryopoiesis and platelet function. Exp Hematol 2012;40:131–142.e134. Epub 2011/ 10/26. doi:10.1016/j.exphem.2011.10.006
   PubMed Web of Science ®Google Scholar
• Mahfoudhi E, Lordier L, Marty C, Pan J, Roy A, Roy L, Rameau P, Abbes S, Debili N, Raslova H, et al. P53 activation inhibits all types of hematopoietic progenitors and all stages of megakaryopoiesis. Oncotarget 2016;7:31980–31992. doi:10.18632/oncotarget.7881
   PubMedGoogle Scholar
• Gilles L, Guieze R, Bluteau D, Cordette-Lagarde V, Lacout C, Favier R, Larbret F, Debili N, Vainchenker W, Raslova H. P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1. Blood 2008;111:4081–4091. doi:10.1182/blood-2007-09-113266
   PubMed Web of Science ®Google Scholar
• Roy L, Coullin P, Vitrat N, Hellio R, Debili N, Weinstein J, Bernheim A, Vainchenker W. Asymmetrical segregation of chromosomes with a normal metaphase/anaphase checkpoint in polyploid megakaryocytes. Blood 2001;97:2238–2247. Epub 2001/ 04/06. doi:10.1182/blood.v97.8.2238
   PubMed Web of Science ®Google Scholar
• Trakala M, Rodriguez-Acebes S, Maroto M, Symonds CE, Santamaria D, Ortega S, Barbacid M, Mendez J, Malumbres M. Functional reprogramming of polyploidization in megakaryocytes. Dev Cell 2015;32:155–167. Epub 2015/ 01/28. doi:10.1016/j.devcel.2014.12.015
   PubMed Web of Science ®Google Scholar
• Geddis AE, Kaushansky K. Endomitotic megakaryocytes form a midzone in anaphase but have a deficiency in cleavage furrow formation. Cell Cycle (georgetown, Tex) 2006;5:538–545. Epub 2006/ 03/23. doi:10.4161/cc.5.5.2537
   PubMed Web of Science ®Google Scholar
• Lordier L, Chang Y, Jalil A, Aurade F, Garcon L, Lecluse Y, Larbret F, Kawashima T, Kitamura T, Larghero J, et al. Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process. Blood 2010;116:2345–2355. Epub 2010/ 06/16. doi:10.1182/blood-2010-01-265785
   PubMed Web of Science ®Google Scholar
• Geddis AE, Kaushansky K. Megakaryocytes express functional Aurora-B kinase in endomitosis. Blood 2004;104:1017–1024. doi:10.1182/blood-2004-02-0419
   PubMed Web of Science ®Google Scholar
• Seki A, Coppinger JA, Jang CY, Yates JR, Fang G. Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry. Science 2008;320:1655–1658. doi:10.1126/science.1157425
   PubMed Web of Science ®Google Scholar
• Macurek L, Lindqvist A, Lim D, Lampson MA, Klompmaker R, Freire R, Clouin C, Taylor SS, Yaffe MB, Medema RH. Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature 2008;455:119–123. doi:10.1038/nature07185
   PubMed Web of Science ®Google Scholar
• Eckerdt F, Maller JL. Kicking off the polo game. Trends Biochem Sci 2008;33:511–513. doi:10.1016/j.tibs.2008.08.004
   PubMed Web of Science ®Google Scholar
• Archambault V, Carmena M. Polo-like kinase-activating kinases: aurora A, Aurora B and what else? Cell Cycle (georgetown, Tex) 2012;11:1490–1495. doi:10.4161/cc.19724
   PubMed Web of Science ®Google Scholar
• Trakala M, Partida D, Salazar-Roa M, Maroto M, Wachowicz P, de Carcer G, Malumbres M. Activation of the endomitotic spindle assembly checkpoint and thrombocytopenia in Plk1-deficient mice. Blood 2015;126:1707–1714. Epub 2015/ 07/18. doi:10.1182/blood-2015-03-634402
   PubMed Web of Science ®Google Scholar
• Goldenson B, Kirsammer G, Stankiewicz MJ, Wen QJ, Crispino JD. Aurora kinase A is required for hematopoiesis but is dispensable for murine megakaryocyte endomitosis and differentiation. Blood 2015;125:2141–2150. Epub 2015/ 02/12. doi:10.1182/blood-2014-12-615401
   PubMed Web of Science ®Google Scholar
• Hickson GR, Echard A, O’Farrell PH. Rho-kinase controls cell shape changes during cytokinesis. Curr Biol 2006;16:359–370. doi:10.1016/j.cub.2005.12.043
   PubMed Web of Science ®Google Scholar
• Wen Q, Goldenson B, Silver SJ, Schenone M, Dancik V, Huang Z, Wang LZ, Lewis TA, An WF, Li X, et al. Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL. Cell 2012;150:575–589. Epub 2012/ 08/07. doi:10.1016/j.cell.2012.06.032
   PubMed Web of Science ®Google Scholar
• Shin JW, Swift J, Spinler KR, Discher DE. Myosin-II inhibition and soft 2D matrix maximize multinucleation and cellular projections typical of platelet-producing megakaryocytes. Proc Natl Acad Sci U S A 2011;108:11458–11463. Epub 2011/ 06/29. doi:10.1073/pnas.1017474108
   PubMed Web of Science ®Google Scholar
• Lordier L, Bluteau D, Jalil A, Legrand C, Pan J, Rameau P, Jouni D, Bluteau O, Mercher T, Leon C, et al. RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidization. Nat Commun 2012;3:717. doi:10.1038/ncomms1704
   PubMed Web of Science ®Google Scholar
• Gao Y, Smith E, Ker E, Campbell P, Cheng EC, Zou S, Lin S, Wang L, Halene S, Krause DS. Role of RhoA-specific guanine exchange factors in regulation of endomitosis in megakaryocytes. Dev Cell 2012;22:573–584. Epub 2012/ 03/06. doi:10.1016/j.devcel.2011.12.019
   PubMed Web of Science ®Google Scholar
• Roy A, Lordier L, Pioche-Durieu C, Souquere S, Roy L, Rameau P, Lapierre V, Le Cam E, Plo I, Debili N, et al. Uncoupling of the Hippo and Rho pathways allows megakaryocytes to escape the tetraploid checkpoint. Haematologica 2016;101:1469–1478. Epub 2016/ 08/16. doi:10.3324/haematol.2016.149914
   PubMed Web of Science ®Google Scholar
• Iancu-Rubin C, Nasrallah CA, Atweh GF. Stathmin prevents the transition from a normal to an endomitotic cell cycle during megakaryocytic differentiation. Cell Cycle (georgetown, Tex) 2005;4:1774–1782. Epub 2005/ 11/01. doi:10.4161/cc.4.12.2171
   PubMed Web of Science ®Google Scholar
• Pawlikowska P, Fouchet P, Vainchenker W, Rosselli F, Naim V. Defective endomitosis during megakaryopoiesis leads to thrombocytopenia in Fanca-/- mice. Blood 2014;124:3613–3623. Epub 2014/ 09/28. doi:10.1182/blood-2014-01-551457
   PubMed Web of Science ®Google Scholar
• Raslova H, Baccini V, Loussaief L, Comba B, Larghero J, Debili N, Vainchenker W. Mammalian target of rapamycin (mTOR) regulates both proliferation of megakaryocyte progenitors and late stages of megakaryocyte differentiation. Blood 2006;107:2303–2310. Epub 2005/ 11/12. doi:10.1182/blood-2005-07-3005
   PubMed Web of Science ®Google Scholar
• Guerriero R, Parolini I, Testa U, Samoggia P, Petrucci E, Sargiacomo M, Chelucci C, Gabbianelli M, Peschle C. Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes. J Cell Sci 2006;119:744–752. Epub 2006/ 02/02. doi:10.1242/jcs.02784
   PubMed Web of Science ®Google Scholar
• Rouyez MC, Boucheron C, Gisselbrecht S, Dusanter-Fourt I, Porteu F. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway. Mol Cell Biol 1997;17:4991–5000. Epub 1997/ 09/01. doi:10.1128/mcb.17.9.4991
   PubMed Web of Science ®Google Scholar
• Mazharian A, Watson SP, Severin S. Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation. Exp Hematol 2009;37:1238–1249.e1235. Epub 2009/ 07/22. doi:10.1016/j.exphem.2009.07.006
   PubMed Web of Science ®Google Scholar
• Eliades A, Papadantonakis N, Matsuura S, Mi R, Bais MV, Trackman P, Ravid K. Megakaryocyte polyploidy is inhibited by lysyl oxidase propeptide. Cell Cycle (georgetown, Tex) 2013;12:1242–1250. Epub 2013/ 03/23. doi:10.4161/cc.24312
   PubMed Web of Science ®Google Scholar
• Eliades A, Matsuura S, Ravid K. Oxidases and reactive oxygen species during hematopoiesis: a focus on megakaryocytes. J Cell Physiol 2012;227:3355–3362. doi:10.1002/jcp.24071
   PubMed Web of Science ®Google Scholar
• Burstein SA, Mei RL, Henthorn J, Friese P, Turner K. Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakaryocytes in vitro. J Cell Physiol 1992;153:305–312. Epub 1992/ 11/01. doi:10.1002/jcp.1041530210
   PubMed Web of Science ®Google Scholar
• Guerriero R, Mattia G, Testa U, Chelucci C, Macioce G, Casella I, Samoggia P, Peschle C, Hassan HJ. Stromal cell-derived factor 1alpha increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells. Blood 2001;97:2587–2595. Epub 2001/ 04/21. doi:10.1182/blood.v97.9.2587
   PubMed Web of Science ®Google Scholar
• Muraoka K, Tsuji K, Yoshida M, Ebihara Y, Yamada K, Sui X, Tanaka R, Nakahata T. Thrombopoietin-independent effect of interferon-gamma on the proliferation of human megakaryocyte progenitors. Br J Haematol 1997;98:265–273. doi:10.1046/j.1365-2141.1997.2303047.x
   PubMed Web of Science ®Google Scholar
• Kuter DJ, Gminski DM, Rosenberg RD. Transforming growth factor beta inhibits megakaryocyte growth and endomitosis. Blood 1992;79:619–626.
   PubMed Web of Science ®Google Scholar
• Giammona LM, Panuganti S, Kemper JM, Apostolidis PA, Lindsey S, Papoutsakis ET, Miller WM. Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition. Exp Hematol 2009;37:1340–1352.e1343. Epub 2009/ 09/01. doi:10.1016/j.exphem.2009.08.004
   PubMed Web of Science ®Google Scholar
• Mercher T, Cornejo MG, Sears C, Kindler T, Moore SA, Maillard I, Pear WS, Aster JC, Gilliland DG. Notch signaling specifies megakaryocyte development from hematopoietic stem cells. Cell Stem Cell 2008;3:314–326. Epub 2008/ 09/13. doi:10.1016/j.stem.2008.07.010
   PubMed Web of Science ®Google Scholar
• Trinh BQ, Barengo N, Kim SB, Lee JS, Zweidler-McKay PA, Naora H. The homeobox gene DLX4 regulates erythro-megakaryocytic differentiation by stimulating IL-1beta and NF-kappaB signaling. J Cell Sci 2015;128:3055–3067. doi:10.1242/jcs.168187
   PubMed Web of Science ®Google Scholar
• Kosoff RE, Aslan JE, Kostyak JC, Dulaimi E, Chow HY, Prudnikova TY, Radu M, Kunapuli SP, McCarty OJ, Chernoff J. Pak2 restrains endomitosis during megakaryopoiesis and alters cytoskeleton organization. Blood 2015;125:2995–3005. Epub 2015/ 04/01. doi:10.1182/blood-2014-10-604504
   PubMed Web of Science ®Google Scholar
• Ichikawa M, Asai T, Saito T, Seo S, Yamazaki I, Yamagata T, Mitani K, Chiba S, Ogawa S, Kurokawa M, et al. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med 2004;10:299–304. doi:10.1038/nm997
   PubMed Web of Science ®Google Scholar
• Antony-Debre I, Bluteau D, Itzykson R, Baccini V, Renneville A, Boehlen F, Morabito M, Droin N, Deswarte C, Chang Y, et al. MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations. Blood 2012;120:2719–2722. doi:10.1182/blood-2012-04-422352
   PubMed Web of Science ®Google Scholar
• Hart A, Melet F, Grossfeld P, Chien K, Jones C, Tunnacliffe A, Favier R, Bernstein A. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 2000;13:167–177.
   PubMed Web of Science ®Google Scholar
• Muntean AG, Pang L, Poncz M, Dowdy SF, Blobel GA, Crispino JD. Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization. Blood 2007;109:5199–5207. Epub 2007/ 02/24. doi:10.1182/blood-2006-11-059378
   PubMed Web of Science ®Google Scholar
• Huang Z, Richmond TD, Muntean AG, Barber DL, Weiss MJ, Crispino JD. STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice. J Clin Invest 2007;117:3890–3899. Epub 2007/ 12/07. doi:10.1172/JCI33010
   PubMed Web of Science ®Google Scholar
• Vilaboa N, Bermejo R, Martinez P, Bornstein R, Cales C. A novel E2 box-GATA element modulates Cdc6 transcription during human cells polyploidization. Nucleic Acids Res 2004;32:6454–6467. doi:10.1093/nar/gkh981
   PubMed Web of Science ®Google Scholar
• Chagraoui H, Kassouf M, Banerjee S, Goardon N, Clark K, Atzberger A, Pearce AC, Skoda RC, Ferguson DJ, Watson SP, et al. SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis. Blood 2011;118:723–735. doi:10.1182/blood-2011-01-328765
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Teramura M, Ito K, Iwabe K, Inaba T, Mizoguchi H. Transcription factor NF-E2 is essential for the polyploidization of a human megakaryoblastic cell line, Meg-J. Biochem Biophys Res Commun 1998;247:65–69. Epub 1998/ 06/24. doi:10.1006/bbrc.1998.8736
   PubMed Web of Science ®Google Scholar
• Gilles L, Bluteau D, Boukour S, Chang Y, Zhang Y, Robert T, Dessen P, Debili N, Bernard OA, Vainchenker W, et al. MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9. Blood 2009;114:4221–4232. doi:10.1182/blood-2009-03-209932
   PubMed Web of Science ®Google Scholar
• Cheng EC, Luo Q, Bruscia EM, Renda MJ, Troy JA, Massaro SA, Tuck D, Schulz V, Mane SM, Berliner N, et al. Role for MKL1 in megakaryocytic maturation. Blood 2009;113:2826–2834. doi:10.1182/blood-2008-09-180596
   PubMed Web of Science ®Google Scholar
• Ragu C, Boukour S, Elain G, Wagner-Ballon O, Raslova H, Debili N, Olson EN, Daegelen D, Vainchenker W, Bernard OA, et al. The serum response factor (SRF)/megakaryocytic acute leukemia (MAL) network participates in megakaryocyte development. Leukemia 2010;24:1227–1230. doi:10.1038/leu.2010.80
   PubMed Web of Science ®Google Scholar
• Smith EC, Teixeira AM, Chen RC, Wang L, Gao Y, Hahn KL, Krause DS. Induction of megakaryocyte differentiation drives nuclear accumulation and transcriptional function of MKL1 via actin polymerization and RhoA activation. Blood 2013;121:1094–1101. doi:10.1182/blood-2012-05-429993
   PubMed Web of Science ®Google Scholar
• Tijssen MR, Cvejic A, Joshi A, Hannah RL, Ferreira R, Forrai A, Bellissimo DC, Oram SH, Smethurst PA, Wilson NK, et al. Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators. Dev Cell 2011;20:597–609. doi:10.1016/j.devcel.2011.04.008
   PubMed Web of Science ®Google Scholar
• Lindsey S, Papoutsakis ET. The aryl hydrocarbon receptor (AHR) transcription factor regulates megakaryocytic polyploidization. Br J Haematol 2011;152:469–484. Epub 2011/ 01/14. doi:10.1111/j.1365-2141.2010.08548.x
   PubMed Web of Science ®Google Scholar
• Yu M, Mazor T, Huang H, Huang HT, Kathrein KL, Woo AJ, Chouinard CR, Labadorf A, Akie TE, Moran TB, et al. Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors. Mol Cell 2012;45:330–343. doi:10.1016/j.molcel.2011.11.032
   PubMed Web of Science ®Google Scholar
• Wilting RH, Yanover E, Heideman MR, Jacobs H, Horner J, van der Torre J, DePinho RA, Dannenberg JH. Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis. Embo J 2010;29:2586–2597. Epub 2010/ 06/24. doi:10.1038/emboj.2010.136
   PubMed Web of Science ®Google Scholar
• Brown AS, Hong Y, de Belder A, Beacon H, Beeso J, Sherwood R, Edmonds M, Martin JF, Erusalimsky JD. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:802–807. doi:10.1161/01.atv.17.4.802
   PubMed Web of Science ®Google Scholar
• Pertuy F, Aguilar A, Strassel C, Eckly A, Freund JN, Duluc I, Gachet C, Lanza F, Leon C. Broader expression of the mouse platelet factor 4-cre transgene beyond the megakaryocyte lineage. J Thromb Haemost 2015;13:115–125. doi:10.1111/jth.12784
   PubMed Web of Science ®Google Scholar
• Guo BB, Allcock RJ, Mirzai B, Malherbe JA, Choudry FA, Frontini M, Chuah H, Liang J, Kavanagh SE, Howman R, et al. Megakaryocytes in myeloproliferative neoplasms have unique somatic mutations. Am J Pathol 2017;187:1512–1522. doi:10.1016/j.ajpath.2017.03.009
   PubMed Web of Science ®Google Scholar
• Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW. The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood 2016;127:2391–2405. doi:10.1182/blood-2016-03-643544
   PubMed Web of Science ®Google Scholar
• Vainchenker W, Kralovics R. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms. Blood 2017;129:667–679. doi:10.1182/blood-2016-10-695940. Epub 2016 Dec 27. Review.
   Web of Science ®Google Scholar
• Gilles L, Arslan AD, Marinaccio C, Wen QJ, Arya P, McNulty M, Yang Q, Zhao JC, Konstantinoff K, Lasho T, et al. Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis. J Clin Invest 2017;127:1316–1320. doi:10.1172/JCI82905
   PubMed Web of Science ®Google Scholar
• Van Den Berghe H. The 5q- syndrome. Scand J Haematol Supplementum 1986;45:78–81. Epub 1986/ 01/01.
   PubMedGoogle Scholar
• Ebert BL, Pretz J, Bosco J, Chang CY, Tamayo P, Galili N, Raza A, Root DE, Attar E, Ellis SR, et al. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 2008;451:335–339. doi:10.1038/nature06494
   PubMed Web of Science ®Google Scholar
• Schneider RK, Adema V, Heckl D, Jaras M, Mallo M, Lord AM, Chu LP, McConkey ME, Kramann R, Mullally A, et al. Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS. Cancer Cell 2014;26:509–520. doi:10.1016/j.ccr.2014.08.001
   PubMed Web of Science ®Google Scholar
• Ribezzo F, Snoeren IAM, Ziegler S, Stoelben J, Olofsen PA, Henic A, Ferreira MV, Chen S, Stalmann USA, Buesche G, et al. Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome. Leukemia 2019;33:1759–1772.
   PubMed Web of Science ®Google Scholar
• Bath PM, Gladwin AM, Carden N, Martin JF. Megakaryocyte DNA content is increased in patients with coronary artery atherosclerosis. Cardiovasc Res 1994;28:1348–1352. doi:10.1093/cvr/28.9.1348
   PubMed Web of Science ®Google Scholar
• Fu W, Meng G, Yang X, Yu L, Jiang H. Bone marrow sympathetic activation regulates post-myocardial infarction megakaryocyte expansion but not platelet production. Biochem Biophys Res Commun 2019;513:99–104. doi:10.1016/j.bbrc.2019.03.160
   PubMed Web of Science ®Google Scholar
• Wen QJ, Yang Q, Goldenson B, Malinge S, Lasho T, Schneider RK, Breyfogle LJ, Schultz R, Gilles L, Koppikar P, et al. Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition. Nat Med 2015;21:1473–1480. Epub 2015/ 11/17. doi:10.1038/nm.3995
   PubMed Web of Science ®Google Scholar
• Gangat N, Marinaccio C, Swords R, Watts JM, Gurbuxani S, Rademaker A, Fought AJ, Frankfurt O, Altman JK, Wen QJ, et al. Aurora kinase A inhibition provides clinical benefit, normalizes megakaryocytes and reduces bone marrow fibrosis in patients with myelofibrosis. Clin Cancer Res 2019. doi:10.1158/1078-0432.CCR-19-1005
   PubMed Web of Science ®Google Scholar
• Wen Q, Leung C, Huang Z, Small S, Reddi AL, Licht JD, Crispino JD. Survivin is not required for the endomitotic cell cycle of megakaryocytes. Blood 2009;114:153–156. Epub 2009/ 04/03. doi:10.1182/blood-2008-11-190801
   PubMed Web of Science ®Google Scholar
• Avanzi MP, Chen A, He W, Mitchell WB. Optimizing megakaryocyte polyploidization by targeting multiple pathways of cytokinesis. Transfusion 2012;52:2406–2413. doi:10.1111/j.1537-2995.2012.03711.x
   PubMed Web of Science ®Google Scholar
• Lannutti BJ, Blake N, Gandhi MJ, Reems JA, Drachman JG. Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656. Blood 2005;105:3875–3878. doi:10.1182/blood-2004-10-3934
   PubMed Web of Science ®Google Scholar
• Gandhi MJ, Drachman JG, Reems JA, Thorning D, Lannutti BJ. A novel strategy for generating platelet-like fragments from megakaryocytic cell lines and human progenitor cells. Blood Cells Mol Dis 2005;35:70–73. doi:10.1016/j.bcmd.2005.04.002
   PubMed Web of Science ®Google Scholar
• Avanzi MP, Goldberg F, Davila J, Langhi D, Chiattone C, Mitchell WB. Rho kinase inhibition drives megakaryocyte polyploidization and proplatelet formation through MYC and NFE2 downregulation. Br J Haematol 2014;164:867–876. Epub 2014/ 01/05. doi:10.1111/bjh.12709
   PubMed Web of Science ®Google Scholar
• Jarocha D, Vo KK, Lyde RB, Hayes V, Camire RM, Poncz M. Enhancing functional platelet release in vivo from in vitro-grown megakaryocytes using small molecule inhibitors. Blood Adv 2018;2:597–606. doi:10.1182/bloodadvances.2017010975
   PubMed Web of Science ®Google Scholar
• Huang H, Woo AJ, Waldon Z, Schindler Y, Moran TB, Zhu HH, Feng GS, Steen H, Cantor AB. A Src family kinase-Shp2 axis controls RUNX1 activity in megakaryocyte and T-lymphocyte differentiation. Genes Dev 2012;26:1587–1601. Epub 2012/ 07/05. doi:10.1101/gad.192054.112
   PubMed Web of Science ®Google Scholar
• Potts KS, Sargeant TJ, Markham JF, Shi W, Biben C, Josefsson EC, Whitehead LW, Rogers KL, Liakhovitskaia A, Smyth GK, et al. A lineage of diploid platelet-forming cells precedes polyploid megakaryocyte formation in the mouse embryo. Blood 2014;124:2725–2729. Epub 2014/ 08/01. doi:10.1182/blood-2014-02-559468
   PubMed Web of Science ®Google Scholar
• Fuchs DA, McGinn SG, Cantu CL, Klein RR, Sola-Visner MC, Rimsza LM. Developmental differences in megakaryocyte size in infants and children. Am J Clin Pathol 2012;138:140–145. doi:10.1309/AJCP4EMTJYA0VGYE
   PubMed Web of Science ®Google Scholar
• Liu ZJ, Italiano J Jr., Ferrer-Marin F, Gutti R, Bailey M, Poterjoy B, Rimsza L, Sola-Visner M. Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes. Blood 2011;117:4106–4117. Epub 2011/ 02/10. doi:10.1182/blood-2010-07-293092
   PubMed Web of Science ®Google Scholar
• Urban D, Pluthero FG, Christensen H, Baidya S, Rand ML, Das A, Shah PS, Chitayat D, Blanchette VS, Kahr WH. Decreased numbers of dense granules in fetal and neonatal platelets. Haematologica 2017;102:e36–e38. doi:10.3324/haematol.2016.152421
   PubMed Web of Science ®Google Scholar
• Baker-Groberg SM, Lattimore S, Recht M, McCarty OJ, Haley KM. Assessment of neonatal platelet adhesion, activation, and aggregation. J Thromb Haemost 2016;14:815–827. doi:10.1111/jth.13270
   PubMed Web of Science ®Google Scholar
• Nakamura S, Takayama N, Hirata S, Seo H, Endo H, Ochi K, Fujita K, Koike T, Harimoto K, Dohda T, et al. Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells. Cell Stem Cell 2014;14:535–548. Epub 2014/ 02/18. doi:10.1016/j.stem.2014.01.011
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang Y, Gao Y, Forbes JA, Qayyum R, Becker L, Cheng L, Wang ZZ. Efficient generation of megakaryocytes from human induced pluripotent stem cells using food and drug administration-approved pharmacological reagents. Stem Cells Transl Med 2015;4:309–319. Epub 2015/ 02/26. doi:10.5966/sctm.2014-0183
   PubMed Web of Science ®Google Scholar
• Lu SJ, Li F, Yin H, Feng Q, Kimbrel EA, Hahm E, Thon JN, Wang W, Italiano JE, Cho J, et al. Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res 2011;21:530–545. Epub 2011/ 01/12. doi:10.1038/cr.2011.8
   PubMed Web of Science ®Google Scholar
• Moreau T, Evans AL, Vasquez L, Tijssen MR, Yan Y, Trotter MW, Howard D, Colzani M, Arumugam M, Wu WH, et al. Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming. Nat Commun 2016;7:11208. doi:10.1038/ncomms11208
   PubMed Web of Science ®Google Scholar
• Liu ZJ, Hoffmeister KM, Hu Z, Mager DE, Ait-Oudhia S, Debrincat MA, Pleines I, Josefsson EC, Kile BT, Italiano J Jr., et al. Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan. Blood 2014;123:3381–3389. Epub 2014/ 03/07. doi:10.1182/blood-2013-06-508200
   PubMed Web of Science ®Google Scholar
• Elagib KE, Lu CH, Mosoyan G, Khalil S, Zasadzinska E, Foltz DR, Balogh P, Gru AA, Fuchs DA, Rimsza LM, et al. Neonatal expression of RNA-binding protein IGF2BP3 regulates the human fetal-adult megakaryocyte transition. J Clin Invest 2017;127:2365–2377. Epub 2017/ 05/10. doi:10.1172/JCI88936
   PubMed Web of Science ®Google Scholar
• Pandit SK, Westendorp B, de Bruin A. Physiological significance of polyploidization in mammalian cells. Trends Cell Biol 2013;23:556–566. Epub 2013/ 07/16. doi:10.1016/j.tcb.2013.06.002
   PubMed Web of Science ®Google Scholar
• Winkelmann M, Pfitzer P, Schneider W. Significance of polyploidy in megakaryocytes and other cells in health and tumor disease. Klin Wochenschr 1987;65:1115–1131. Epub 1987/ 12/01. doi:10.1007/bf01734832
   PubMedGoogle Scholar
• Raslova H, Roy L, Vourc’h C, Le Couedic JP, Brison O, Metivier D, Feunteun J, Kroemer G, Debili N, Vainchenker W. Megakaryocyte polyploidization is associated with a functional gene amplification. Blood 2003;101:541–544. Epub 2002/ 10/24. doi:10.1182/blood-2002-05-1553
   PubMed Web of Science ®Google Scholar
• Hilpert M, Legrand C, Bluteau D, Balayn N, Betems A, Bluteau O, Villeval JL, Louache F, Gonin P, Debili N, et al. p19 INK4d controls hematopoietic stem cells in a cell-autonomous manner during genotoxic stress and through the microenvironment during aging. Stem Cell Rep 2014;3:1085–1102. doi:10.1016/j.stemcr.2014.10.005
   PubMed Web of Science ®Google Scholar
• Ganem NJ, Cornils H, Chiu SY, O’Rourke KP, Arnaud J, Yimlamai D, Thery M, Camargo FD, Pellman D. Cytokinesis failure triggers hippo tumor suppressor pathway activation. Cell 2014;158:833–848. Epub 2014/ 08/16. doi:10.1016/j.cell.2014.06.029
   PubMed Web of Science ®Google Scholar